Going against a decade of rulings, a federal
appeals court said payments
aimed at holding back generics were anticompetitive, setting up possible review by the
Supreme Court.
Source -
http://feeds.nytimes.com/click.phdo?i=df39ac2a816cc2ce42130cbcf9f30875
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন